GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enhabit Inc (NYSE:EHAB) » Definitions » GF Value

Enhabit (Enhabit) GF Value : $0.00 (As of May. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enhabit GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-25), Enhabit's share price is $8.84. Enhabit's GF Value is $0.00. Therefore, Enhabit's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Enhabit is Not Valued.


Enhabit  (NYSE:EHAB) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Enhabit's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=8.84/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enhabit GF Value Related Terms

Thank you for viewing the detailed overview of Enhabit's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Enhabit (Enhabit) Business Description

Traded in Other Exchanges
Address
6688 N. Central Expressway, Suite 1300, Dallas, TX, USA, 75206
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health agencies provide a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services.
Executives
Jeffrey Bolton director 1016 CIVIC CENTER DRIVE NW, ROCHESTER MN 55901
Shaw L Edward Jr director AETNA INC, 151 FARMINGTON AVE RC4B, HARTFORD CT 06156
Stuart M Mcguigan director 74 AGAMENTICUS AVENUE, CAPE NEDDICK ME 03902
Barry P. Schochet director 100 EAST RIVERCENTER BLVD, 16TH FLOOR, COVINGTON KY 41011
Dylan C Black officer: General Counsel and Secretary 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Langham Ronald Leroy Jr officer: EVP Clinical Excel. & Strategy 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Higdon Leo I Jr director 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Gregory S Rush director TEKELEC, 26580 W. AGOURA RD., CALABASAS CA 91302
Tina L. Brown-stevenson director 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Erin Hoeflinger director 511 FALLVIEW COURT, SPRINGBORO OH 45066
Tanya Renee Marion officer: Chief Human Resources Officer 6688 NORTH CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Charles M Elson director 1401 61STG STREET S, STETSON UNIV COLLEGE OF LAW, ST PETERSBURG FL 33707
Barbara Ann Jacobsmeyer director, officer: President and CEO 2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Yvonne M Curl director C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Maupin John E Jr D D S director 103 POWELL COURT SUITE 200, BRENTWOOD TN 37027